Validation of stimulated ∆FGF19 for diagnosing bile acid diarrhoea
Phase of Trial: Phase IV
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Chenodeoxycholic acid (Primary)
- Indications Primary bile acid malabsorption
- Focus Diagnostic use
- Acronyms VABAD
- 22 Jun 2017 Planned primary completion date changed from 30 Jun 2017 to 30 Sep 2017.
- 03 Apr 2017 Status changed from not yet recruiting to recruiting.
- 26 Dec 2016 New trial record